1-8 of 8
Santiago Gardella
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized Phase II Study Comparing Consolidation With a Single Dose Of 90 y Ibritumomab Tiuxetan (Zevalin®) (Z) Vs. Maintenance With Rituximab (R) For Two Years In Patients With Newly Diagnosed Follicular Lymphoma (FL) Responding To R-CHOP. Preliminary Results At 36 Months From Randomization

Armando Lopez-Guillermo, MD, PhD, Miguel A. Canales, MD, PhD, Ivan Dlouhy, Javier Briones, MD, Dolores Caballero, MD, PhD, Juan Manuel Sancho, Sr., MD, Santiago Mercadal Vilchez, MD, Jose María Moraleda, MD, María José Terol, MD, PhD, Antonio Salar, MD, Luis Palomera, MD, Santiago Gardella, MD, Isidro Jarque, MD, Secundino Ferrer, Joan Bargay, MD, Andres Lopez, Carlos Panizo, Anna Muntanola, MD, Carlos Montalban, Eulogio Conde, MD, PhD, Miguel Hernandez, MD, Alfons Soler, Julian Marin, MD, Jose García Marco, Guillermo Deben, José Francisco Tomas, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 369.
https://doi.org/10.1182/blood.V122.21.369.369
Published: 2013
Journal Articles

Long-Term Follow-up of Patients with HIV-Related Diffuse Large B-Cell Lymphoma (DLBCL) Treated in the Phase II Study with Rituximab and CHOP (R-CHOP)

Josep-Maria Ribera, MD, PhD, Mireia Morgades, Albert Oriol, Eva González-Barca, MD, Pilar Miralles, Armando Lopez-Guillermo, Santiago Gardella, Andrés López, Eugènia Abella, Blanca Xicoy, MD, Marta Garcia, Evarist Feliu, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4980.
https://doi.org/10.1182/blood.V118.21.4980.4980
Published: 2011
Journal Articles

Clinical and Biological Prognostic Factors Evaluation of Diffuse Large B-Cell Lymphoma Patients Relapsed or Refractory After Previous Line with Rituximab Plus Chemotherapy. Results of the Study PRO-R-IPI (NCT01369784),

Carlos Panizo, MD, Anny Jaramillo, MD, Gonzalo Gutierrez-Garcia, Francisco Javier Díaz, Eva González-Barca, MD, Raquel de Oña, Nerea Castro, Juan Manuel Sancho, María Flor García-Alvarez, Blanca Sanchez-Gonzalez, MD, PhD, Francisco Javier Peñalver, Jimena Cannata-Ortiz, Manuel Espeso, María José Requena, Santiago Gardella, Soledad Durán, Ana Pilar González-Rodríguez, Ricardo García-Muñoz, Maurizio Bendandi, MD, PhD, Dolores Caballero, MD
Journal: Blood
Blood (2011) 118 (21): 3654.
https://doi.org/10.1182/blood.V118.21.3654.3654
Published: 2011
Journal Articles

Therapeutic Compliance and Efficacy of Dose-Dense R-CHOP-14 Immunochemotherapy Plus Pegfilgrastim for First-Line Treatment of Low Risk Diffuse Large B-Cell Lymphoma Patients: Preliminary Results of An Open-Label Clinical Trial in Spain

Eva Gonzalez-Barca, Sr., Miguel Canales, III, Antonio Salar, MD, PhD, Secundino Ferrer, Joan Bargay, S. Grande, Santiago Gardella, María Jesús Vidal, Albert Oriol, MD, A. López, J. García, Jl Bello, Fj Tomás, Javier Briones, Dolores Caballero
Journal: Blood
Blood (2008) 112 (11): 4943.
https://doi.org/10.1182/blood.V112.11.4943.4943
Published: 2008
Journal Articles

Efficacy of Dose-Dense R-CHOP-14 Chemoimmunotherapy Plus Pegfilgrastim for First-Line Treatment of Diffuse Large B-Cell Lymphoma (DLBCL) in Low Risk Patients: An Interim Analysis of an Open-Label Clinical Trial in Spain. On Behalf of GEL/TAMO (Spanish Group of Lymphoma).

Eva Gonzalez-Barca, Antonio Salar, Joan Bargay, Jose F. Tomas, Miguel A. Canales, Jose M. Moraleda, Maria Jesus Vidal, Secundino Ferrer, Javier Briones, Cristina Estany, Santiago Gardella, Andres Llorente, Dolores Caballero
Journal: Blood
Blood (2007) 110 (11): 3443.
https://doi.org/10.1182/blood.V110.11.3443.3443
Published: 2007
Journal Articles

Prognostic Value of Immunophenotyping of Multiple Myeloma: A Study on 685 Patients Uniformly Treated with High-Dose Therapy.

Gema Mateo, PhD, Maria A. Montalban, MD, Maria-Belén Vidriales, MD, Juan J. Lahuerta, MD, Maria-Victoria Mateos, MD, Norma C. Gutiérrez, MD, Laura Rosiñol, MD, Laura Montejano, MD, Ma Consuelo López-Berges, MD, Joan Bladé, MD, Rafael Martínez, MD, Javier de la Rubia, MD, Joaquín Diaz-Mediavilla, MD, Anna Sureda, MD, José M. Ribera, MD, José M. Ojanguren, MD, Felipe de Arriba, MD, Luis Palomera, MD, Ma José Terol, MD, Santiago Gardella, MD, Alberto Orfao, MD, J.F. San Miguel
Journal: Blood
Blood (2007) 110 (11): 1472.
https://doi.org/10.1182/blood.V110.11.1472.1472
Published: 2007
Journal Articles

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA

Clinical Trials & Observations
Joan Bladé, Laura Rosiñol, Ana Sureda, Josep M. Ribera, Joaquín Díaz-Mediavilla, José García-Laraña, M. Victoria Mateos, Luis Palomera, Javier Fernández-Calvo, Josep M. Martí, Pilar Giraldo, Félix Carbonell, Manel Callís, Jesús Trujillo, Santiago Gardella, M. Jesús Moro, Abelardo Barez, Alfons Soler, Llorenç Font, Montserrat Fontanillas, Jesús San Miguel, for Programa para el Estudio de la Terapéutica en Hemopatía Maligna (PETHEMA)
Journal: Blood
Blood (2005) 106 (12): 3755–3759.
https://doi.org/10.1182/blood-2005-03-1301
Published: 2005
Journal Articles

Treatment with Rituximab, CHOP and Highly Active Antiretroviral Therapy (HAART) in AIDS-Related Diffuse Large B-Cell Lymphomas (DLBCL). Study of 60 Patients.

Josep-María Ribera, PhD, Albert Oriol, MD, Mireia Morgades, MD, Eva González-Barca, MD, Pilar Miralles, MD, Armando Lopez-Guillermo, MD, Andres Lopez, MD, Blanca Xicoy, MD, Eugenia Abella, MD, Santiago Gardella, MD, Marta García, MD, Joan Bargay, MD, Katy Perez-Equiza, MD, Javier Briones, MD, Lluis Rodriguez, MD, Mariano Provencio, MD, Lourdes Escoda, MD, Alfons Soler, MD, Miguel Canales, MD, Antonio Asensio, MD, Antonio Romero, MD, Secundino Ferrer, MD, Evarist Feliu, MD
Journal: Blood
Blood (2005) 106 (11): 774.
https://doi.org/10.1182/blood.V106.11.774.774
Published: 2005